Subscribe to RSS
DOI: 10.1055/s-0030-1258113
One-Pot Synthesis of α-Alkylidene-γ-butyrolacton-2-ones (Tetronic Acid Derivatives): Polar Solvent Induces a New Type of γ-Lactonization
Publication History
Publication Date:
30 June 2010 (online)
![](https://www.thieme-connect.de/media/synlett/201012/lookinside/thumbnails/10.1055-s-0030-1258113-1.jpg)
Abstract
An efficient, one-pot synthetic protocol toward α-alkylidene-γ-butyrolacton-2-ones, a rather unexplored class of heterocyclic scaffolds starting from primary amines, methyl acetoacetate, and chloroacetyl chloride is described. The mixture of MeCN-MeOH as a polar solvent triggers a new cycloaddition of the enaminone intermediate. The reaction is completed within 12 hours under reflux condition to produce the title compounds.
Key words
γ-lactone - α-alkylidene-γ-butyrolactone - tetronic acid - enaminone - chloroacetyl chloride - polar solvent - one-pot multicomponent reaction
- 1
Raphael RA.Ravenscroft P. J. Chem. Soc., Perkin Trans. 1 1988, 1823 - 2
Dueholm KL.Pederson LB. Synthesis 1992, 1 - 3
Robertson DW.Krushinski JH.Utterback BG.Kauffman RF. J. Med. Chem. 1989, 32: 1476 - 4
Bjeldanes LF. J. Org. Chem. 1977, 42: 2333 - 5
Weidner-Wells MA.Decamp A.Mazzocchi PH.
J. Org. Chem. 1989, 54: 5746 - 6
Von Hoffman HMR.Rabe J. Angew. Chem., Int. Ed. Engl. 1985, 97: 94 - 7
Rücker G.Gajewski W. J. Med. Chem. 1985, 20: 87 - 8
Streibl M.Nawrot J.Herout V. Biochem. Syst. Ecol. 1983, 11: 381 - 9
Ley SV.Toogood PL. Chem. Brit. 1990, 31 - 10
Paruch E. Wiadomosci Chemiczne 2001, 55: 93 -
11a
Moise J.Arseniyadis S.Cossy J. Org. Lett. 2007, 9: 1695 -
11b
Raju R.Allen L.Le T.Taylor C.Howell A. Org. Lett. 2007, 9: 1699 -
11c
Oh S.Jeong IH.Shin WS.Wang Q.Lee S. Bioorg. Med. Chem. Lett. 2006, 16: 1656 -
12a
Janecki T.Blaszczyk E.Janecka A.Krajewaska U.Rozalski M. J. Med. Chem. 2005, 48: 3516 -
12b
Huang WC.Chan ST.Yang TL.Tzeng CC.Chen CC. Carcinogenesis 2004, 25: 1925 -
13a
De Bernardi M.Garlaschelli L.Toma L.Vidari G.Vita-Finzi P. Tetrahedron 1991, 47: 7109 -
13b
Vidari G.Lanfranchi G.Pazzi N.Serra S. Tetrahedron Lett. 1999, 40: 3063 -
13c
Jung M.Lee S.Yoon B. Tetrahedron Lett. 1997, 38: 2871 -
13d
Tesaki S.Kikuzaki H.Yonemori S.Nakatani N. J. Nat. Prod. 2001, 64: 515 -
14a
De D.Seth M.Bhaduri AP. Synthesis 1990, 956 -
14b
Ohta T.Miyake T.Seido N.Kumobayashi H.Takaya H. J. Org. Chem. 1995, 60: 357 -
14c
Arcadi A.Chiarini M.Marinelli F.Berente Z.Kollàr L. Org. Lett. 2000, 2: 69 - 15
Otto A.Liebscher J. Synthesis 2003, 1209 - 16
Gasperi T.Loreto MA.Tardella PA.Veri E. Tetrahedron Lett. 2003, 44: 4953 -
17a
Castulík J.Marek J.Mazal C. Tetrahedron 2001, 57: 8339 -
17b
Otto A.Ziemer B.Liebscher J. Synthesis 1999, 965 -
18a
Otto A.Ziemer B.Liebscher J. Eur. J. Org. Chem. 1998, 2667 -
18b
Otto A.Abegaz B.Ziemer B.Liebscher J. Tetrahedron: Asymmetry 1999, 10: 3381 -
18c
Nishimura K.Tomioka K. J. Org. Chem. 2002, 67: 431 - 19
Read de Alaniz J.Rovis T. J. Am. Chem. Soc. 2005, 127: 6284 -
20a
Neelakantan S.Seshadri TR. Current Sci. (India) 1959, 28: 476 -
20b
Haynes LJ.Plimmer JR. Quart. Rev. 1960, 14: 292 -
20c
Brodersen R.Kjaer A. Acta Pharmacol. Toxicol. 1946, 2: 109 -
21a
Effenberger F.Syed J. Tetrahedron: Asymmetry 1998, 9: 817 -
21b
Bühler H.Bayer A.Effenberger F. Chem. Eur. J. 2000, 6: 2564 - 22
Kasettrathat C.Ngamrojanavanich N.Wiyakrutta S.Mahidol C.Ruchirawat S.Kittakoop P. Phytochemistry 2008, 69: 2621 -
23a
Schobert R.Schlenk A. Bioorg. Med. Chem. 2008, 16: 4203 -
23b
Pevet I.Meyer C.Cossy J. Tetrahedron Lett. 2001, 42: 5215 -
23c
Bourdreux Y.Bodio E.Willis C.Billaud C.Gall T.Mioskowski C. Tetrahedron 2008, 64: 8930 -
23d
Mitsos CA.Zografos AL.Igglessi-Markopoulou O. J. Org. Chem. 2000, 65: 5852 -
23e
Sodeoka M.Sampe R.Kojima S.Baba Y.Usui T.Ueda K.Osada H. J. Med. Chem. 2001, 44: 3216 -
23f
Peukert S.Sun Y.Zhang R.Hurley B.Sabio M.Shen X.Gray C.Dzink-Fox J.Tao J.Cebula R.Wattanasin S. Bioorg. Med. Chem. Lett. 2008, 18: 1840 -
23g
Schobert R.Urbina-Gonzalez JM. Tetrahedron Lett. 2005, 46: 3657 -
24a
Ramachandran P.Garner G.Pratihar D. J. Org. Lett. 2007, 9: 4753 -
24b
Moïse J.Arseniyadis S.Cossy J. Org. Lett. 2007, 9: 1695 -
24c
Seitz M.Reiser O. Curr. Opin. Chem. Biol. 2005, 9: 285 -
24d
Yavari I.Hossaini Z. Tetrahedron Lett. 2006, 47: 4465 -
24e
Zhang Q.Lu X.Han X. J. Org. Chem. 2001, 66: 7676 -
24f
Kitson RRA.Taylor RJK.Wood JL. Org. Lett. 2009, 11: 5338 -
24g
Ramachandran PV.Pratiharorg D. Org. Lett. 2007, 9: 2087 -
24h
Moise J.Arseniyadis S.Cossy J. Org. Lett. 2007, 9: 1695 -
24i
Ramachandran PV.Garner G.Pratihar D. Org. Lett. 2007, 9: 4753 -
25a
Alizadeh A.Movahedi F.Esmaili AA. Tetrahedron Lett. 2006, 47: 4469 -
25b
Alizadeh A.Movahedi F.Masrour H.Zhu LG. Synthesis 2006, 3431 -
25c
Alizadeh A.Rezvanian A.Zhu LG. Tetrahedron 2008, 64: 351 -
25d
Alizadeh A.Rezvanian A.Bijanzadeh HR. Synthesis 2008, 725 -
25e
Alizadeh A.Babaki M.Zohreh N. Tetrahedron 2009, 65: 1704 -
25f
Alizadeh A.Babaki M.Zohreh N. Synthesis 2008, 3295
References and Notes
To a magnetically stirred 10 mL flat-bottom
flask, containing ethylamine (0.09 g, 2 mmol) was added methyl acetoacetate
(0.24 g, 2 mmol), and this mixture was stirred at r.t. under solvent-free
conditions for 10 min. A solution of chloroacetyl chloride (0.22
g, 2 mmol) in MeCN (5 mL) was added dropwise to the reaction mixture.
The progress of the reaction was followed by TLC. When enaminone 5 was fully consumed, MeOH (2 mL) was added
and the mixture allowed to stir at 110-120 ˚C
for 11 h. After completion of the reaction, the solvent was removed
under reduced pressure. The residue was purified by column chromatog-raphy
on silica gel (n-hexane-EtOAc = 1:1)
to obtain product 4a as a white powder
(0.12 g, 71%). IR (KBr): 3460 (NH), 1728 (CO2),
1638 (C=O), 1615 (C=C) cm-¹.
MS (EI, 70 eV): m/z (%) = 169
(93) [M+], 151 (85), 123 (38),
95 (34), 82 (69), 68 (50), 58 (100), 42 (92).
E-Isomer of 4a: ¹H
NMR (500.13 MHz, CDCl3): δ = 1.35
(3 H, t, ³
J
H,H = 7.3
Hz, CH2CH
3), 2.54
(3 H, s, CH3), 3.47 (2 H, q, ³
J
H,H = 7.3
Hz, CH
2CH3), 4.40
(2 H, s, CH2O), 10.99 (1 H, s, NH). ¹³C
NMR (125.75 MHz, CDCl3): δ = 13.86 (CH2
CH3), 14.42 (CH3),
38.43 (CH2CH3),
69.97 (OCH2), 91.76 (C=CCH3),
170.80 (C=CCH3),
172.52 (CO2), 197.10 (C=O).
Z-isomer of 4a: ¹H
NMR (500.13 MHz, CDCl3): δ = 1.32
(3 H, t, ³
J
H,H = 7.3
Hz, CH2CH
3), 2.58
(3 H, s, CH3), 3.50 (2 H, q, ³
J
H,H = 7.3
Hz, CH
2CH3), 4.38
(2 H, s, CH2O), 10.01 (1 H, s, NH). ¹³C
NMR (125.75 MHz, CDCl3): δ = 14.27 (CH2
CH3), 14.62 (CH3),
38.12 (CH2CH3),
72.00 (OCH2), 90.36 (C=CCH3),
169.94 (C=CCH3),
176.35 (CO2), 193.62 (C=O).
Compound 4b: yield 0.28 g (80%); white
powder; mp 112-114 ˚C. IR (KBr): 3465
(NH), 1734 (CO2), 1661 (C=O), 1604 (C=C)
cm-¹. MS (EI, 70 eV): m/z (%) = 183
(100) [M+], 165 (87), 154
(70), 150 (59), 137 (39), 125 (47), 97 (75), 82 (72), 67 (70).
E-isomer of 4b: ¹H
NMR (500.13 MHz, CDCl3): δ = 1.05
(3 H, t, ³
J
H,H = 7.4
Hz, CH2CH
3), 1.75
(2 H, q, ³
J
H,H = 7.4
Hz, CH
2CH3), 2.55
(3 H, s, CH3), 3.43 (2 H, t, ³
J
H,H = 6.9
Hz, CH2N), 4.42 (2 H, s, OCH2), 11.10 (1 H,
s, NH). ¹³C NMR (125.75 MHz, CDCl3): δ = 11.16
(CH2
CH3), 13.96
(CH3), 30.87 (CH2CH3),
45.18 (CH2N), 69.97 (CH2O), 91.88 (C=CCH3), 161.90 (C=CCH3), 170.96 (CO2),
197.18 (C=O).
Z-isomer
of 4b: ¹H NMR (500.13
MHz, CDCl3): δ = 1.03
(3 H, t, ³
J
H,H = 7.4
Hz, CH2CH
3), 1.72
(2 H, q, ³
J
H,H = 7.4
Hz, CH
2CH3), 2.60
(3 H, s, CH3), 3.40 (2 H, t, ³
J
H,H = 7.0
Hz, CH2N), 4.40 (2 H, s, OCH2), 10.13 (1 H,
s, NH). ¹³C NMR (125.75 MHz, CDCl3): δ = 11.16
(CH2
CH3), 14.37
(CH3), 31.22 (CH2CH3),
44.85 (CH2N), 72.04 (CH2O), 90.44 (C=CCH3), 161.93 (C=CCH3), 170.07 (CO2),
193.61 (C=O).
Compound 4e:
yield 0.28 g (82%); white powder; mp 118-120 ˚C.
IR (KBr): 3230 (NH), 1725 (CO2), 1639 (C=O), 1604
(C=C) cm-¹. MS (EI, 70 eV): m/z (%) = 183
(100) [M+], 165 (78), 137
(24), 110 (39), 96 (94), 83 (47), 67 (35), 55 (16).
E-isomer of 4e: ¹H
NMR (500.13 MHz, CDCl3): δ = 1.30
(6 H, d, ³
J
H,H = 6.2
Hz, 2 CHCH
3), 2.51 (3 H, s,
CH3), 3.91-3.99 (1 H, m, 1 CHCH3),
4.33 (2 H, s, CH2O), 10.94 (1 H, s, NH). ¹³C
NMR (125.75 MHz, CDCl3): δ = 13.85
(2 CHCH3), 22.82 (CH3),
45.75 (CHCH3), 69.89 (CH2O), 91.43
(C=CCH3), 169.43
(C=CCH3), 172.53
(CO2), 196.96 (C=O).
Z-isomer
of 4e: ¹H NMR (500.13
MHz, CDCl3): δ = 1.28
(6 H, d, ³
J
H,H = 6.2
Hz, 2 CHCH
3), 2.56 (3 H, s,
CH3), 3.91-3.99 (1 H, m, CHCH3),
4.30 (2 H, s, CH2O), 9.94 (1 H, s, NH). ¹³C
NMR (125.75 MHz, CDCl3): δ = 14.31
(2 CHCH3), 22.78 (CH3),
45.41 (CHCH3), 71.84 (CH2O), 90.05
(C=CCH3), 168.61
(C=CCH3), 176.31
(CO2), 193.58 (C=O).